切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2020, Vol. 09 ›› Issue (06) : 515 -518. doi: 10.3877/cma.j.issn.2095-3232.2020.06.004

所属专题: 综述 文献

专家论坛

合并肥胖肝移植患者减重手术策略
李乐1, 曲伟2, 张宇红2, 肖飞2, 朱志军2,()   
  1. 1. 100045 北京,首都医科大学附属北京友谊医院肝脏移植中心;024000 内蒙古自治区赤峰市医院肝胆外科
    2. 100045 北京,首都医科大学附属北京友谊医院肝脏移植中心
  • 收稿日期:2020-09-06 出版日期:2020-12-10
  • 通信作者: 朱志军

Bariatric surgery strategy for liver transplant patients complicated with obesity

Le Li1, Wei Qu2, Yuhong Zhang2   

  • Received:2020-09-06 Published:2020-12-10
引用本文:

李乐, 曲伟, 张宇红, 肖飞, 朱志军. 合并肥胖肝移植患者减重手术策略[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 09(06): 515-518.

Le Li, Wei Qu, Yuhong Zhang. Bariatric surgery strategy for liver transplant patients complicated with obesity[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2020, 09(06): 515-518.

[1]
Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity among adults: United States, 2011-2012[J]. NCHS Data Brief, 2013(131):1-8.
[2]
Ward ZJ, Long MW, Resch SC, et al. Redrawing the US obesity landscape: bias-corrected estimates of state-specific adult obesity prevalence[J]. PLoS One, 2016, 11(3): e0150735.
[3]
Moss BG, Yeaton WH. Young children's weight trajectories and associated riskfactors: results from the Early Childhood Longitudinal Study-Birth Cohort[J]. Am J Health Promot, 2011, 25(3):190-198.
[4]
Zaydfudim V, Feurer ID, Moore DE, et al. The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation[J]. Surgery, 2009, 146(2):174-180.
[5]
Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States[J]. Hepatology, 2002, 35(1):105-109.
[6]
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States[J]. Gastroenterology, 2011, 141(4):1249-1253.
[7]
Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J]. Gastroenterology, 2015, 148(3):547-555.
[8]
Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis[J]. J Clin Gastroenterol, 2006, 40 Suppl 1:S11-16.
[9]
Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation[J]. Liver Transpl, 2012, 18(10): 1147-1153.
[10]
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation[J]. Am J Transplant, 2004, 4(5):686-693.
[11]
Saab S, Cho D, Lassman RC, et al. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient[J].J Hepatol, 2005, 42(1):148-149.
[12]
Lim LG, Cheng CL, Wee A, et al. Prevalence and clinical associations of posttransplant fatty liver disease[J]. Liver Transpl, 2007, 27(1):76-80.
[13]
Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events[J]. Liver Transpl, 2011, 17(1):15-22.
[14]
McAlister VC, Haddad E, Renouf E, et al. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis[J]. Am J Transplant, 2006, 6(7):1578-1585.
[15]
Dumortier J, Giostra E, Belbouab S, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil"[J]. Am J Gastroenterol, 2010, 105(3):613-620.
[16]
Perkins JD. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation[J]. Liver Transpl, 2006, 12(6):1012-1013.
[17]
Ayloo S, Armstrong J, Hurton S, et al. Obesity and liver transplantation[J]. World J Transplant, 2015, 5(3):95-101.
[18]
中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011, 27(9):711-717.
[19]
Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates[J]. Surg Obes Relat Dis, 2013, 9(5):653-658.
[20]
Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation[J]. Surg Obes Relat Dis, 2008, 4(2):159-164.
[21]
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease[J]. Am J Transplant, 2013, 13(2):363-368.
[22]
Zamora-Valdes D, Watt KD, Kellogg TA, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy[J]. Hepatology, 2018, 68(2):485-495.
[23]
Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation[J]. Obes Surg, 2007, 17(11):1517-1519.
[24]
Suraweera D, Dutson E, Saab S. Liver transplantation and bariatric surgery: best approach[J]. Clin Liver Dis, 2017, 21(2):215-230.
[25]
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation[J]. Surg Endosc, 2013, 27(1):81-85.
[26]
Osseis M, Lazzati A, Salloum C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes[J]. Obes Surg, 2018, 28(1): 242-248.
[27]
Toolabi K, Golzarand M, Farid R. Laparoscopic adjustable gastric banding: efficacy and consequences over a 13-year period[J]. Am J Surg, 2016, 212(1):62-68.
[28]
Vu L, Switzer NJ, De Gara C, et al. Surgical interventions for obesity and metabolic disease[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(2):239-246.
[29]
Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity[J]. Cochrane Database Syst Rev, 2009(2):CD003641.
[30]
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study[J]. Ann Surg, 2008, 247(3):401-407.
[31]
Moshiri M, Osman S, Robinson TJ, et al. Evolution of bariatric surgery:a historical perspective[J]. AJR Am J Roentgenol, 2013, 201(1):W40-48.
[32]
Tavakol MM, Amirkiai S, Amin R, et al. Laparoscopic sleeve gastrectomy (LSG) is safe, well tolerated and improves candidacy in morbidly obese patients awaiting liver transplantation[J]. Transplantation, 2012, 94 Suppl:226.
[33]
Campsen J, Zimmerman M, Shoen J, et al. Adiustable gastric banding in a morbidly obese patient during liver transplantation[J]. Obes Surg, 2008, 18(12):1625-1627.
[34]
Guerrero Pérez F, Pia Marengo A, Fabregat J, et al. Combined sleeve gastrectomy and orthotopic liver transplantation in patient with type 2 obesity and advanced liver disease[J]. Endocrinol Diabates Nutr, 2017, 64(5):282-284.
[35]
Kumar S, Khandelwal N, Kumar A, et al. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-first report from India[J]. Indian J Gastroenterol, 2017, 36(3):243-247.
[36]
Nesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity?[J]. Obes Surg, 2017, 27(5):1387-1390.
[37]
Tariciotti L, D'Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: first European case-report[J]. Int J Surg Case Rep, 2016(28):38-41.
[38]
Elli EF, Masrur MA, Giulianotti PC. Robotic sleeve gastrectomy after liver transplantation[J]. Surg Obes Relat Dis, 2013, 9(1):e20-22.
[39]
Pajecki D, Cesconetto DM, Macacari R, et al. Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report[J]. Arq Bras Cir Dig, 2014, 27 Suppl 1:81-83.
[40]
Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation[J]. Liver Transpl, 2013, 19(12):1324-1329.
[41]
Lainas P, Dupond-Athenor A, Tranchart H, et al. Safety and feasibility of single-port sleeve gastrectomy following liver transplantation[J]. Obes Surg, 2018, 28(3):874-876.
[42]
Yemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression[J]. Am J Transplant, 2018, 18(11):2772-2780.
[43]
Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity[J]. Transplantation, 2001, 72(1):156-159.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[3] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[4] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[5] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[6] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[8] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[9] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[10] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[11] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[12] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[14] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[15] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?